Fulgent Genetics, Inc. (FLGT)
Largest Insider Buys in Sector
FLGT Stock Price History Chart
FLGT Stock Performance
About Fulgent Genetics, Inc.
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for somatic cancer testing; rapid whole genome testing for children in NICU and PICU; newborn genetic analysis panel; single front-line test to detect ataxia-related …
Insider Activity of Fulgent Genetics, Inc.
Over the last 12 months, insiders at Fulgent Genetics, Inc. have bought $0 and sold $320,971 worth of Fulgent Genetics, Inc. stock.
On average, over the past 5 years, insiders at Fulgent Genetics, Inc. have bought $0 and sold $7.25M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 17,478 shares for transaction amount of $43,240 was made by Hsieh Ming (President and CEO) on 2019‑03‑05.
List of Insider Buy and Sell Transactions, Fulgent Genetics, Inc.
| 2024-12-03 | Sale | Chief Scientific Officer | 1,373 0.0045% | $19.50 | $26,773 | +1.76% | ||
| 2024-12-03 | Sale | President and COO | 1,455 0.0048% | $19.50 | $28,372 | +1.76% | ||
| 2024-11-25 | Sale | Chief Scientific Officer | 497 0.0016% | $18.26 | $9,075 | +6.82% | ||
| 2024-11-25 | Sale | Chief Executive Officer | 2,227 0.0072% | $18.26 | $40,663 | +6.82% | ||
| 2024-11-25 | Sale | President and COO | 689 0.0022% | $18.26 | $12,581 | +6.82% | ||
| 2024-09-03 | Sale | Chief Scientific Officer | 1,503 0.005% | $21.96 | $33,007 | -7.37% | ||
| 2024-09-03 | Sale | President and COO | 1,594 0.0053% | $21.96 | $35,006 | -7.37% | ||
| 2024-09-03 | Sale | CFO and Treasurer | 1,674 0.0056% | $21.96 | $36,763 | -7.37% | ||
| 2024-08-27 | Sale | Chief Scientific Officer | 563 0.0019% | $22.83 | $12,855 | -11.41% | ||
| 2024-08-27 | Sale | Chief Executive Officer | 2,313 0.0076% | $22.83 | $52,813 | -11.41% | ||
| 2024-08-27 | Sale | President and COO | 715 0.0024% | $22.83 | $16,326 | -11.41% | ||
| 2024-08-27 | Sale | CFO and Treasurer | 733 0.0024% | $22.83 | $16,737 | -11.41% | ||
| 2023-12-11 | Sale | President and COO | 22,000 0.0746% | $26.52 | $583,453 | -17.38% | ||
| 2023-12-04 | Sale | Chief Scientific Officer | 1,437 0.0049% | $27.57 | $39,623 | -20.30% | ||
| 2023-12-04 | Sale | President and COO | 1,779 0.006% | $27.57 | $49,053 | -20.30% | ||
| 2023-12-04 | Sale | CFO and Treasurer | 1,437 0.0049% | $27.57 | $39,623 | -20.30% | ||
| 2023-11-16 | Sale | President and COO | 1,617 0.0054% | $27.25 | $44,065 | -19.25% | ||
| 2023-11-16 | Sale | CFO and Treasurer | 1,307 0.0043% | $27.25 | $35,617 | -19.25% | ||
| 2023-09-07 | Sale | Chief Scientific Officer | 1,041 0.0035% | $31.41 | $32,696 | -24.20% | ||
| 2023-09-07 | Sale | President and COO | 1,492 0.005% | $31.41 | $46,861 | -24.20% |
Insider Historical Profitability
| Hsieh Ming | Chief Executive Officer | 703711 2.3007% | $18.51 | 18 | 3 | +22.28% |
Institutional Investor Ownership
| BlackRock | $85.08M | 13.1 | 3.92M | +4.22% | +$3.44M | <0.01 | |
| The Vanguard Group | $30.91M | 4.76 | 1.42M | +0.58% | +$179,176.91 | <0.01 | |
| Dimensional Fund Advisors | $29.19M | 4.5 | 1.35M | -7.06% | -$2.22M | 0.01 | |
| State Street | $17.89M | 2.76 | 824,477 | +1.42% | +$250,526.50 | <0.01 | |
| Park West Asset Management Llc | $15.84M | 2.44 | 729,783 | +71.8% | +$6.62M | 1.19 |